Australian court to rule on whether Bayer weedkiller can cause blood cancer
By Peter Hobson and Alasdair Pal
CANBERRA, July 25 (Reuters) -An Australian judge will rule on Thursday on whether Bayer's BAYGn.DE Roundup weedkiller can cause a type of blood cancer, a closely watched decision that follows some jury verdicts in similar U.S. cases that have found for the plaintiffs.
On Thursday, Justice Michael Lee of Australia's Federal Court will only rule on whether Roundup can cause non-Hodgkins lymphoma and not on whether subsidiaries of Bayer were negligent regarding the risks its products posed and should pay damages.
The hearing, which will take place in Sydney, is due to start at 3:15 p.m. (0515 GMT).
The German pharmaceutical and chemicals company has maintained that Roundup, a glyphosate-based herbicide, is safe. It says it "fully stands behind its glyphosate-based products, which have been used around the world for almost 50 years."
The Australian class action against Bayer subsidiaries unites more than 1,000 claimants and is one of some 40 cases filed outside the United States, all in either Canada or Australia.
The lead claimant is 41-year-old Kelvin McNickle, who says he used Roundup to spray weeds for over two decades on his family's property and while working for a vegetation management company. He developed non-Hodgkins lymphoma aged 35.
In the United States, Bayer has prevailed in 14 of the last 20 Roundup trials, but it also racked up a string of losses in late 2023 and early 2024, resulting in more than $4 billion damages awarded in verdicts.
Some of those verdicts have seen the amounts awarded reduced but the cases shattered investor and company hopes that the worst of the Roundup litigation was over.
The company faces more than 50,000 outstanding claims in the United States. A request for an agreement to prevent future cases was denied by a U.S. court.
Roundup was originally produced by U.S. agrochemical company Monsanto, which Bayer acquired for $63 billion in 2018.
The company has replaced glyphosate with new active ingredients in its products for household use in the United States to reduce the risk of litigation as most claims have come from home users.
It continues to sell glyphosate-based weedkillers to farmers, who rely on it heavily.
Reporting by Peter Hobson in Canberra and Alasdair Pal in Sydney; Editing by Edwina Gibbs
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
